The ASCO Annual Meeting is being held June 2 to 6, and here is some of the notable research that will be presented today. Topics include treatment for anemia related to myelodysplastic syndromes, pembrolizumab for advanced cervical cancer, surgery options for early pancreatic cancer, weight loss in breast cancer survivorship, the effect of Medicare expansion on racial disparities, and collaborating across borders to help children with leukemia.
Hagumimana Robert shares what it was like when his mother received her cancer diagnosis, what cancer care is like in his country of Uganda, and what he learned about supporting a loved one with cancer during his mother’s experience.
Pancreatic cancer survivor Dr. Rachel Orgel describes what it was like being diagnosed with cancer as a teenager, how she coped with multiple recurrences, and how she navigated finding her new identity post-cancer.
Radiation oncologist and cancer survivor Dr. Arthur Hamberger shares how being diagnosed with cancer led him to a career in oncology, what it was like being diagnosed with multiple cancers 45 years later, and his advice on coping with a cancer diagnosis.
2022 ASCO Annual Meeting: Improving Standard Care for Advanced Pancreatic Cancer and Older Adults with Mantle Cell Lymphoma
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s studies explore adding nimotuzumab to chemotherapy to treat KRAS wild-type pancreatic cancer and adding ibrutinib to standard care for older adults with mantle cell lymphoma.
Using Aspirin to Prevent Breast Cancer Recurrence and Targeted Therapy for Treating Advanced Pancreatic Cancer: The ASCO Plenary Series
Read research from the February 2022 session of the ASCO Plenary Series, which highlights a study on daily aspirin to prevent breast cancer recurrence and another on using targeted therapy to treat advanced pancreatic cancer with a specific mutation.
Dr. Mark A. Lewis describes what the Whipple procedure is, including who might receive it, what his personal experience with the operation was like, how to prepare, and what to expect during recovery from the operation.
Dr. Arjun Gupta explains what pancreatic enzyme replacement therapy is, why it may be offered to people with pancreatic cancer, and what to expect if you’re receiving this supportive care therapy.
The 2020 Advance of the Year in ASCO’s Clinical Cancer Advances report is the refinement of surgical treatment of cancer.
In these “Your Stories” podcasts from Conquer Cancer, the ASCO Foundation, individuals share their experiences with clinical trials.